Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Adial Pharmaceuticals Inc (ADIL)

Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adial Pharmaceuticals Inc 4870 Sadler Road Suite 300 Glen Allen VA 23060 USA

www.adialpharma.com P: 804-487-8196

Description:

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. The company's lead product consists of AD04 which is in clinical stage. Adial Pharmaceuticals Inc. is based in CHARLOTTESVILLE.

Key Statistics

Overview:

Market Capitalization, $K 7,015
Enterprise Value, $K 4,185
Shares Outstanding, K 4,055
Annual Sales, $ 0 K
Annual Net Income, $ -5,120 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,920 K
EBIT, $ -6,890 K
EBITDA, $ -6,830 K
60-Month Beta 1.48
% of Insider Shareholders 14.47%
% of Institutional Shareholders 16.41%
Float, K 3,468
% Float 85.53%
Short Volume Ratio 0.51

Growth:

1-Year Return -81.06%
3-Year Return -96.85%
5-Year Return -97.61%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 91.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.14 on 11/14/23
Latest Earnings Date 05/10/24
Earnings Per Share ttm -5.22
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 62.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/07/23

ADIL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -250.52%
Return-on-Assets % -183.24%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.69
Book Value/Share 2.46
Interest Coverage -0.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar